According to Fortune Business Insights, the global potassium iodide market size was valued at USD 0.72 billion in 2025 and is projected to grow from USD 0.76 billion in 2026 to USD 1.22 billion by 2034, exhibiting a CAGR of 6.1% during the forecast period. Asia Pacific dominated the potassium iodide market, accounting for 38.88% of the market in 2025.
The market is witnessing steady growth due to increasing demand for iodine-based pharmaceutical products, rising awareness of iodine deficiency disorders, expanding food fortification programs, and growing applications in laboratory and industrial processes. Increasing investments in healthcare infrastructure and chemical manufacturing are further supporting market expansion.
Key Market Drivers
Growing Demand from the Pharmaceutical Industry
The increasing use of potassium iodide in thyroid disorder treatment, iodine supplementation, and pharmaceutical formulations is driving market growth.
Rising Awareness of Iodine Deficiency
Government initiatives promoting iodine supplementation and food fortification programs are increasing global demand for potassium iodide.
Expanding Industrial and Laboratory Applications
Growing utilization of potassium iodide in chemical synthesis, analytical laboratories, and research activities is supporting market expansion.
Market Restraints
Fluctuating Raw Material Availability
Variations in iodine supply and raw material prices can affect manufacturing costs and market stability.
Regulatory Compliance Requirements
Stringent regulations governing pharmaceutical-grade and food-grade potassium iodide products may increase production and quality assurance costs.
Get Sample PDF Here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/potassium-iodide-market-116620
Market Opportunities
Increasing Demand for Nutritional Fortification
Growing emphasis on preventive healthcare and micronutrient supplementation is creating new opportunities for potassium iodide in fortified food products.
Expansion of Pharmaceutical Manufacturing
Rising investments in pharmaceutical production, particularly in emerging economies, are expected to support long-term market growth.